1. Home
  2. GRNQ vs BNGO Comparison

GRNQ vs BNGO Comparison

Compare GRNQ & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$1.62

Market Cap

17.5M

Sector

Technology

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.30

Market Cap

14.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNQ
BNGO
Founded
2013
2003
Country
Malaysia
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
14.3M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
GRNQ
BNGO
Price
$1.62
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
12.7K
120.5K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
$3,673,997.00
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
24.55
26.26
52 Week Low
$1.00
$1.06
52 Week High
$3.18
$5.50

Technical Indicators

Market Signals
Indicator
GRNQ
BNGO
Relative Strength Index (RSI) 27.05 56.35
Support Level $1.25 $1.09
Resistance Level $1.88 $1.33
Average True Range (ATR) 0.17 0.06
MACD -0.10 0.01
Stochastic Oscillator 0.91 56.55

Price Performance

Historical Comparison
GRNQ
BNGO

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: